Análisis de factores de riesgo adicionales para la fibrosis hepática en pacientes diabéticos con enfermedad renal crónica terminal

Organización Mundial de la Salud. Tabaco y diabetes - Resúmenes de conocimientos de la OMS sobre el tabaco [Internet]. OPS/OMS; 2024 [consultado el 16 de mayo de 2024]. Disponible en: https://www.paho.org/es/documentos/tabaco-diabetes-resumenes-conocimientos-oms-sobre-tabaco

Feng L, Chen C, Xiong X, Wang X, Li X, Kuang Q, et al. PS-MPs promotes the progression of inflammation and fibrosis in diabetic nephropathy through NLRP3/Caspase-1 and TGF-β1/Smad2/3 signaling pathways. Ecotoxicol Environ Saf. 2024:273:116102. https://doi.org/10.1016/j.ecoenv.2024.116102

Matsumoto A, Nagasawa Y, Yamamoto R, Shinzawa M, Yamazaki H, Shojima K, et al. Cigarette smoking and progression of kidney dysfunction: a longitudinal cohort study. Clin Exp Nephrol. 2024;28(8):793-802. https://doi.org/10.1007/s10157-024-02487-6

Lampimukhi M, Qassim T, Venu R, Pakhala N, Mylavarapu S, Perera T, et al. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma. Cureus. 2023;15(11):e49429. https://doi.org/10.7759/cureus.49429

Tadokoro T, Morishita A, Himoto T, Masaki T. Nutritional Support for Alcoholic Liver Disease. Nutrients. 2023;15(6):1360. https://doi.org/10.3390/nu15061360

Dukić M, Radonjić T, Jovanović I, Zdravković M, Todorović Z, Kraišnik N, et al. Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease. Int J Mol Sci. 2023;24(4):3735. https://doi.org/10.3390/ijms24043735